The advancement of a series of ligand efficient 2-amino-[1,2,4]triazolo[1,5-a]pyridines, initially identified from high-throughput screening, to a JAK2 inhibitor with pharmacodynamic activity in a mouse xenograft model is disclosed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmcl.2013.06.008 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!